Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN
Clinical trial NCT03726775 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03726775
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2026-07-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.